JAK2 mutation analysis and then a bone marrow biopsy might be a reasonable way to confirm the definite diagnosis after assessment of the characteristics of patients with thrombocytosis and causes of reactive thrombocytosis. Here, JAK2 is linked to thrombocytosis disease.